Spots Global Cancer Trial Database for philadelphia chromosome positive adult precursor acute lymphoblastic leukemia

Every month we try and update this database with for philadelphia chromosome positive adult precursor acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	NCT00061945	Acute Undiffere... B-cell Adult Ac... B-cell Childhoo... L1 Adult Acute ... L1 Childhood Ac... L2 Adult Acute ... L2 Childhood Ac... Philadelphia Ch... Philadelphia Ch... Philadelphia Ch... T-cell Adult Ac... T-cell Childhoo... Untreated Adult... Untreated Child...	allopurinol cyclophosphamid... daunorubicin hy... vincristine sul... dexamethasone asparaginase filgrastim imatinib mesyla... methotrexate cytarabine trimethoprim-su... mercaptopurine leucovorin calc... alemtuzumab acyclovir laboratory biom... pharmacological...	15 Years -	National Cancer Institute (NCI)
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia	NCT00723203	Leukemia	panobinostat gene expression... reverse transcr... laboratory biom...	18 Years -	City of Hope Medical Center
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	NCT01383447	Philadelphia Ch... Recurrent Adult...	entinostat imatinib mesyla... laboratory biom... pharmacological... western blottin... immunohistochem... flow cytometry polymerase chai... high performanc... mass spectromet...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00844298	Leukemia	Nilotinib+mVPD	15 Years -	Asan Medical Center
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant	NCT01475058	Philadelphia Ch... Philadelphia Ch... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Mantl... Refractory Chro...	allogeneic cyto...	18 Years - 75 Years	Fred Hutchinson Cancer Center
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia	NCT00816283	Leukemia	dasatinib vorinostat cytogenetic ana... gene expression... mutation analys... reverse transcr... flow cytometry laboratory biom...	18 Years -	City of Hope Medical Center
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia	NCT01925131	Acute Leukemias... B-cell Adult Ac... Philadelphia Ch... Recurrent Adult... Recurrent Adult...	cyclophosphamid... vincristine sul... prednisone inotuzumab ozog... laboratory biom...	18 Years -	SWOG Cancer Research Network
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant	NCT01475058	Philadelphia Ch... Philadelphia Ch... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Mantl... Refractory Chro...	allogeneic cyto...	18 Years - 75 Years	Fred Hutchinson Cancer Center
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01085617	Leukemia Mucositis Oral Complicati...	palifermin rituximab cyclophosphamid... cytarabine daunorubicin hy... etoposide fludarabine pho... imatinib mesyla... melphalan mercaptopurine methotrexate nelarabine pegaspargase vincristine sul... allogeneic hema... total-body irra...	25 Years - 65 Years	University College, London

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: